Serumconcentrations of apoptotic markers such as soluble FasL, granzyme B and cytochrome c were
increased after administration of the first cycle of chemotherapeutic drugs. Themeasurement of these circulating
apoptotic markers may help clinicians in evaluating treatment efficacy in breast cancer